A new company, PFerrinX26, is planning to enter the lactoferrin market by building a precision fermentation facility in the Midwest. Lactoferrin is an iron-binding protein found in mammalian milk, with benefits for human health, but has historically been costly to isolate from milk. The company is backed by Earth First Food Ventures Ltd (EFFV), which has assembled a consortium of players from the big dairy, dextrose providers, off-takers, CPG, and ingredient companies to fund a facility capable of producing 200 tons of bovine lactoferrin in the coming years. The facility will utilize genetically engineered microbes to produce lactoferrin, which can be used in various applications such as cosmetics, adult nutrition, and infant formula. The company aims to reduce costs by using continuous fermentation technology and novel approaches. The market demand for lactoferrin is expected to grow, driven by the increasing popularity of dairy alternatives, the aging population, and the growing demand for protein-enriched foods and supplements.
A new player in the lactoferrin market is building a precision fermentation facility in the US.
